Electrophoretic characterization of LNP/AAV-encapsulated nucleic acids: Strengths and weaknesses.

Hutanu, Andrei; Ferreiro, Miriam López; van Haasteren, Joost; Höcker, Oliver; Montealegre, Cristina; Mäser, Marina; Keresztfalvi, Alex; Monti, Jose; Schwarz, Maria Anna

Hutanu, Andrei; Ferreiro, Miriam López; van Haasteren, Joost; Höcker, Oliver; Montealegre, Cristina; Mäser, Marina; Keresztfalvi, Alex; Monti, Jose; Schwarz, Maria Anna.

Afiliação

Hutanu A; Pharma Technical Development, Cell and Gene Therapy Unit, F. Hoffmann-La Roche AG, Basel, Switzerland.
Ferreiro ML; Department of Chemistry, University of Basel, Basel, Switzerland.
van Haasteren J; Pharma Technical Development, Cell and Gene Therapy Unit, F. Hoffmann-La Roche AG, Basel, Switzerland.
Höcker O; Pharma Technical Development, Cell and Gene Therapy Unit, F. Hoffmann-La Roche AG, Basel, Switzerland.
Montealegre C; Solvias AG, Kaiseraugst, Switzerland.
Mäser M; Solvias AG, Kaiseraugst, Switzerland.
Keresztfalvi A; Solvias AG, Kaiseraugst, Switzerland.
Monti J; Solvias AG, Kaiseraugst, Switzerland.
Schwarz MA; Solvias AG, Kaiseraugst, Switzerland.

Electrophoresis ; 44(19-20): 1595-1606, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37625008

Palavras-chave

CGE; IP-RP-LC; lipid nanoparticle; peptide nucleic acid; recombinant adeno associated virus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Electrophoresis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça